1. Vassallo, A., Wood, A.J., Subburayalu, J., Summers, C., & Chilvers, E.R. The counter-intuitive role of the neutrophil in the acute respiratory distress syndrome. Br. Med. Bull. 131(1), 43-55 (2019).
2. Matthay, M. A. et al. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers. 14(5), 18 (2019).
3. de la Rica, R., Borges, M., & Gonzalez-Freire, M. COVID-19: In the Eye of the Cytokine Storm. Front. Immunol. 11, 558898 (2020).
4. Horby, P. W. & Landray M. J. Randomised Evaluation of 13 COVID-19 Therapy (RECOVERY) trial. 2021. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. Preprint at https://doi.org/10.1101/2021.02.11.21249258 (2021).
5. Potey, P. M., Rossi, A. G., Lucas, C. D., & Dorward, D. A. Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential. The Journal of pathology 247(5), 672–685 (2019).
6. Brown, K. A. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157-169 (2006).
7. Opal, S. M. Immunologic alterations and the pathogenesis of organ failure in the ICU. Semin. Resp. Crit. Care Med. 32, 569-580 (2011).
8. Xu, J. et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15, 1318-1321 (2009).
9. Yang, H. et al. New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation. Front. Immunol. 7, 302 (2016).
10. Wang, Y. et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in acute respiratory distress syndrome patients: a retrospective study. J. Thorac. Dis. 10, 273-282 (2018).
11. Jimeno, S. et al. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur. J. Clin. Invest. 51(1), e13404 (2021).
12. Chua, R. L. et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 38(8), 970-979 (2020).
13. Silvin, A. et al. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell 182(6),1401-1418 (2020).
14. Guo, Q. et al. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe. 29(2),222-235 (2021)
15. Schulte-Schrepping, J. et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell 182(6), 1419-1440 (2020).
16. Gromisch, C. M. et al. Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model. BMC Cancer 21, 407 (2021).
17. Moulding, D. A., Quayle, J. A., Hart, C. A., & Edwards, S. W. Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 92(7), 2495–2502 (1998).
18. Filep, J. G. & El Kebir, D. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. J. Cell Biochem. 108(5), 1039-1046 (2009).
19. Herrera, V. L. et al. Embryonic lethality in Dear gene deficient mice: new player in angiogenesis. Physiol. Genomics 23, 257-268 (2005).
20. Druml, W. et al. Endothelin-1 in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148(5), 1169-1173 (1993).
21. Zouki, C. et al. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br. J. Pharmacol. 127(4), 969-979 (1999).
22. Jorch, S. & Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med 23, 279–287 (2017).
23. Vassallo, A., Wood, A.J., Subburayalu, J., Summers, C., & Chilvers, E.R. The counter-intuitive role of the neutrophil in the acute respiratory distress syndrome. British Medical Bulletin 131(1), 43-55 (2019).
24. Herrera, V. L. et al. Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein. BMC Mol. Biol. 17, 15 (2016).
25. Juss, J.K. et al. Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition. Am. J. Respir. Crit. Care Med. 194(8), 961-973 (2016).
26. Mendonça, R., Silveira, A.A.A. & Conran, N. Red cell DAMPs and inflammation. Inflamm. Res. 65, 665–678 (2016).
27. Xiang, M. & Fan, J. Pattern Recognition Receptor-Dependent Mechanisms of Acute Lung Injury. Mol. Med. 16, 69–82 (2010).
28. Aboudounya, M. M. & Heads, R. J. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediators Inflamm. 2021, 8874339 (2021).
29. Zhou, X. et al. LPS activation of Toll-like receptor 4 signals CD11b/CD18 expression in neutrophils. Am. J. Physiol. Lung Cell Mol. Physiol. 288(4), L655-L662 (2005).
30. Odobasic, D., Kitching, A.R. & Holdsworth, S.R. Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase. J. Immunol. Res. 2016, 2349817 (2016).
31. van der Veen, B.S., de Winther, M.P. & Heeringa, P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal. 11(11), 2899-2937 (2009).
32. Bordon, J. et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int. J. Infect. Dis. 17(2), e76-83 (2013).
33. Hojyo, S. et al. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regener. 40, 37 (2020).
34. Butt, Y., Kurdowska, A. & Allen, T.C. Acute Lung Injury: A Clinical and Molecular Review. Arch. Pathol. Lab. Med. 140(4), 345-350 (2016).
35. Finsterbusch, M. et al. Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus. Proc. Natl. Acad. Sci. U.S.A. 113(35), E5172-E5181 (2016).
36. Liu, Y. et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of infection 81(1), e6–e12 (2020).
37. Arcanjo, A. et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci. Rep. 10(1), 19630 (2020).
38. Veras, F. P. et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 217(12), e20201129 (2020).
39. Krishnamoorthy, N. et al. Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma. Sci. Immunol. 3(26), eaao4747 (2018).
40. Jundi, B. et al. Leukocyte function assessed via serial microlitre sampling of peripheral blood from sepsis patients correlates with disease severity. Nat. Biomed. Eng. 3, 961–973 (2019).
41. Bjornson-Hooper, Z. B. et al. A comprehensive atlas of immunological differences between humans, mice and non-human primates. bioRxiv (2019) preprint doi: https://doi.org/10.1101/574160
42. Herrera, V. L. et al. DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a ‘common receptor coordinator’ paradigm. PLoS One 9(1), e85821 (2014).
43. Grégoire, M. et al. Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS. Eur. Respir. J. 52(2), 1702590 (2018).
44. Wu, Y. et al. Adenosine deaminase that acts on RNA 1 p150 in alveolar macrophage is involved in LPS-induced lung injury. Shock. 31(4), 410-415 (2009).
45. Choudhury, A. & S. Mukherjee, S. In silico studies on the comparative characterization of the interactions of SARS CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J. Med. Virol. 92(10), 2105–2113 (2020).
46. Wang, S. et al. S100A8/A9 in Inflammation. Front. Immunol. 9, 1298 (2018).
47. Kuipers, M.T. et al. High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling. PLoS One. 8(7), e68694 (2013).
48. Chen, L. et al. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol 17, 992–994 (2020)
49. Yipp, B.G., & Kubes, P. NETosis: how vital is it? Blood 122(16), 2784-2794 (2013).
50. Yipp, B.G. & Kubes, P. NETosis: how vital is it? Blood. 122(16), 2784-2794 (2013).
51. Yousefi, S. et al. Untangling "NETosis" from NETs. Eur J Immunol. 49(2), 221-227 (2019).
52. Klok, F. A. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 191, 148-150 (2020).
53. Gattinoni, L. et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 46, 1099-1102 (2020).
54. Fox, S., Leitch, A. E., Duffin, R., Haslett, C., & Rossi, A. G. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J. Innate Immun. 2(3), 216–227 (2010).
55. Brown, K. A. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157-169 (2006).
56. Camous, L. et al. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood. 117(4), 1340-1349 (2011).
57. Skendros, P. et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Invest. 130(11), 6151-6157 (2020).
58. El Kebir, D. & Filep, J. G. Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins. Front. Immunol. 4, 60 (2013).
59. Hamaguchi, S. et al. Identification of neutrophil extracellular traps in the blood of patients with systemic inflammatory response syndrome. J. Int. Med. Res. 41(1), 162-168 (2013).